EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company, today reported that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for U. S. patent application 11/120,306 entitled “Permeation Enhancing Compositions For Anticholinergic Agents” related to Antares’ Anturol™ product for the treatment of overactive bladder. The Notice of Allowance is the USPTO’s official communication that the Company’s application has successfully completed examination and that a patent will be issued.
